The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru

Hreem B. Dave, Luz Gordillo, Zhou Yang, Monica S. Zhang, G. Baker Hubbard, Timothy Olsen

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: To determine the cost-effectiveness of laser treatment for retinopathy of prematurity (ROP) in Lima, Peru. Design: A cost-of-illness study (in US dollars) to determine the direct cost of treatment, the indirect lifetime cost of blindness, and the quality-adjusted life years. Methods: The direct cost of ROP-related treatment was determined by reviewing data retrospectively from a social security sector hospital. The indirect cost was determined using national economic data of Peru published by the Central Information Agency (CIA), including the per capita gross domestic product, the sex-adjusted income distribution, and years spent in the work force. Indirect costs per child that were avoided by treatment were calculated using the known natural history of ROP vs evidence-based treatment. Results: For ROP-related neonatal blindness in Peru, we estimate the total indirect cost saving at $197 753 per child and the direct cost of laser treatment at $2496 per child. The societal lifetime cost saving per child is estimated at $195 257. The mean annual income per educated adult in Peru is $8000 and treating 1 child is equivalent to employing 24 educated Peruvians per year. The generational cost savings for society is approximately $516 million, or the equivalent of 64 500 educated Peruvian work years. Conclusions: The societal burden of blindness far exceeds the costs of treatment per child. Proper screening and treatment of ROP prevents blindness and leads to substantial cost savings for society. Public health policy in Peru and other middle-income countries should consider financial impact when allocating healthcare resources.

Original languageEnglish (US)
Pages (from-to)750-755
Number of pages6
JournalAmerican journal of ophthalmology
Volume154
Issue number4
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Fingerprint

Retinopathy of Prematurity
Peru
Blindness
Costs and Cost Analysis
Health Care Costs
Cost Savings
Lasers
Gross Domestic Product
Therapeutics
Cost of Illness
Quality-Adjusted Life Years
Social Security
Public Policy
Health Policy
Cost-Benefit Analysis
Public Health
Economics
Delivery of Health Care

ASJC Scopus subject areas

  • Ophthalmology

Cite this

The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru. / Dave, Hreem B.; Gordillo, Luz; Yang, Zhou; Zhang, Monica S.; Hubbard, G. Baker; Olsen, Timothy.

In: American journal of ophthalmology, Vol. 154, No. 4, 01.10.2012, p. 750-755.

Research output: Contribution to journalArticle

Dave, Hreem B. ; Gordillo, Luz ; Yang, Zhou ; Zhang, Monica S. ; Hubbard, G. Baker ; Olsen, Timothy. / The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru. In: American journal of ophthalmology. 2012 ; Vol. 154, No. 4. pp. 750-755.
@article{870638254b5a408f988c10cfc221f7dc,
title = "The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru",
abstract = "Purpose: To determine the cost-effectiveness of laser treatment for retinopathy of prematurity (ROP) in Lima, Peru. Design: A cost-of-illness study (in US dollars) to determine the direct cost of treatment, the indirect lifetime cost of blindness, and the quality-adjusted life years. Methods: The direct cost of ROP-related treatment was determined by reviewing data retrospectively from a social security sector hospital. The indirect cost was determined using national economic data of Peru published by the Central Information Agency (CIA), including the per capita gross domestic product, the sex-adjusted income distribution, and years spent in the work force. Indirect costs per child that were avoided by treatment were calculated using the known natural history of ROP vs evidence-based treatment. Results: For ROP-related neonatal blindness in Peru, we estimate the total indirect cost saving at $197 753 per child and the direct cost of laser treatment at $2496 per child. The societal lifetime cost saving per child is estimated at $195 257. The mean annual income per educated adult in Peru is $8000 and treating 1 child is equivalent to employing 24 educated Peruvians per year. The generational cost savings for society is approximately $516 million, or the equivalent of 64 500 educated Peruvian work years. Conclusions: The societal burden of blindness far exceeds the costs of treatment per child. Proper screening and treatment of ROP prevents blindness and leads to substantial cost savings for society. Public health policy in Peru and other middle-income countries should consider financial impact when allocating healthcare resources.",
author = "Dave, {Hreem B.} and Luz Gordillo and Zhou Yang and Zhang, {Monica S.} and Hubbard, {G. Baker} and Timothy Olsen",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.ajo.2012.04.003",
language = "English (US)",
volume = "154",
pages = "750--755",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - The societal burden of blindness secondary to retinopathy of prematurity in Lima, Peru

AU - Dave, Hreem B.

AU - Gordillo, Luz

AU - Yang, Zhou

AU - Zhang, Monica S.

AU - Hubbard, G. Baker

AU - Olsen, Timothy

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Purpose: To determine the cost-effectiveness of laser treatment for retinopathy of prematurity (ROP) in Lima, Peru. Design: A cost-of-illness study (in US dollars) to determine the direct cost of treatment, the indirect lifetime cost of blindness, and the quality-adjusted life years. Methods: The direct cost of ROP-related treatment was determined by reviewing data retrospectively from a social security sector hospital. The indirect cost was determined using national economic data of Peru published by the Central Information Agency (CIA), including the per capita gross domestic product, the sex-adjusted income distribution, and years spent in the work force. Indirect costs per child that were avoided by treatment were calculated using the known natural history of ROP vs evidence-based treatment. Results: For ROP-related neonatal blindness in Peru, we estimate the total indirect cost saving at $197 753 per child and the direct cost of laser treatment at $2496 per child. The societal lifetime cost saving per child is estimated at $195 257. The mean annual income per educated adult in Peru is $8000 and treating 1 child is equivalent to employing 24 educated Peruvians per year. The generational cost savings for society is approximately $516 million, or the equivalent of 64 500 educated Peruvian work years. Conclusions: The societal burden of blindness far exceeds the costs of treatment per child. Proper screening and treatment of ROP prevents blindness and leads to substantial cost savings for society. Public health policy in Peru and other middle-income countries should consider financial impact when allocating healthcare resources.

AB - Purpose: To determine the cost-effectiveness of laser treatment for retinopathy of prematurity (ROP) in Lima, Peru. Design: A cost-of-illness study (in US dollars) to determine the direct cost of treatment, the indirect lifetime cost of blindness, and the quality-adjusted life years. Methods: The direct cost of ROP-related treatment was determined by reviewing data retrospectively from a social security sector hospital. The indirect cost was determined using national economic data of Peru published by the Central Information Agency (CIA), including the per capita gross domestic product, the sex-adjusted income distribution, and years spent in the work force. Indirect costs per child that were avoided by treatment were calculated using the known natural history of ROP vs evidence-based treatment. Results: For ROP-related neonatal blindness in Peru, we estimate the total indirect cost saving at $197 753 per child and the direct cost of laser treatment at $2496 per child. The societal lifetime cost saving per child is estimated at $195 257. The mean annual income per educated adult in Peru is $8000 and treating 1 child is equivalent to employing 24 educated Peruvians per year. The generational cost savings for society is approximately $516 million, or the equivalent of 64 500 educated Peruvian work years. Conclusions: The societal burden of blindness far exceeds the costs of treatment per child. Proper screening and treatment of ROP prevents blindness and leads to substantial cost savings for society. Public health policy in Peru and other middle-income countries should consider financial impact when allocating healthcare resources.

UR - http://www.scopus.com/inward/record.url?scp=84866391936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866391936&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2012.04.003

DO - 10.1016/j.ajo.2012.04.003

M3 - Article

C2 - 22831839

AN - SCOPUS:84866391936

VL - 154

SP - 750

EP - 755

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 4

ER -